
Patients at the Point of Care
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
How are advances in point-of-care testing altering the genetic testing landscape, and what does this mean for the clinical lab?
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests
A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?